NO774294L - Fremgangsmaate ved fremstilling av nye piperazinderivater - Google Patents
Fremgangsmaate ved fremstilling av nye piperazinderivaterInfo
- Publication number
- NO774294L NO774294L NO774294A NO774294A NO774294L NO 774294 L NO774294 L NO 774294L NO 774294 A NO774294 A NO 774294A NO 774294 A NO774294 A NO 774294A NO 774294 L NO774294 L NO 774294L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- piperazine derivatives
- preparing new
- new piperazine
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU76RI605A HU174215B (hu) | 1976-12-15 | 1976-12-15 | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO774294L true NO774294L (no) | 1978-06-16 |
| NO147306B NO147306B (no) | 1982-12-06 |
| NO147306C NO147306C (no) | 1983-03-16 |
Family
ID=11001009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO774294A NO147306C (no) | 1976-12-15 | 1977-12-14 | Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US4140790A (no) |
| JP (2) | JPS6026114B2 (no) |
| AT (1) | AT359507B (no) |
| BE (1) | BE861849A (no) |
| CA (1) | CA1080219A (no) |
| CH (1) | CH632750A5 (no) |
| DE (1) | DE2755707A1 (no) |
| ES (1) | ES465061A1 (no) |
| FI (1) | FI65427C (no) |
| FR (1) | FR2374322A1 (no) |
| GB (1) | GB1580227A (no) |
| HU (1) | HU174215B (no) |
| IL (1) | IL53552A (no) |
| IN (1) | IN146474B (no) |
| NL (1) | NL7713827A (no) |
| NO (1) | NO147306C (no) |
| PT (1) | PT67403B (no) |
| SE (1) | SE430159B (no) |
| SU (1) | SU694071A3 (no) |
| YU (1) | YU293677A (no) |
| ZA (1) | ZA777398B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU174215B (hu) * | 1976-12-15 | 1979-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
| US4703120A (en) * | 1986-04-28 | 1987-10-27 | Ortho Pharmaceutical Corporation | Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof |
| CN1060168C (zh) * | 1994-05-06 | 2001-01-03 | 中国人民解放军军事医学科学院毒物药物研究所 | 新的呫吨衍生物，其制备方法及含它们的药物组合物 |
| EP1474420B1 (en) | 2002-02-01 | 2012-03-14 | AstraZeneca AB | Quinazoline compounds |
| EP1611116A2 (en) * | 2003-04-08 | 2006-01-04 | Neuromed Technologies, Inc. | Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| US20080207738A1 (en) * | 2007-02-28 | 2008-08-28 | Cancure Laboratories, Llc | Drug combinations to treat drug resistant tumors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3481930A (en) * | 1966-11-21 | 1969-12-02 | American Home Prod | Xanthene and thioxanthene-9 ureas and propionamides |
| US3502662A (en) * | 1968-03-18 | 1970-03-24 | American Home Prod | N-(9-xanthenyl or thioxanthenyl)-3-amino or iodo-propionamides and 4-(9-xanthenyl or thioxanthenyl)-thiosemicarbazones |
| FR2201084B1 (no) * | 1972-09-29 | 1975-10-31 | Bouchara Emile | |
| GB1437868A (en) * | 1973-05-09 | 1976-06-03 | Synthelabo | Arylpiperazinoalkyl esters |
| HU174215B (hu) * | 1976-12-15 | 1979-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
-
1976
- 1976-12-15 HU HU76RI605A patent/HU174215B/hu unknown
-
1977
- 1977-11-25 JP JP52140843A patent/JPS6026114B2/ja not_active Expired
- 1977-12-02 CH CH1475877A patent/CH632750A5/de not_active IP Right Cessation
- 1977-12-05 AT AT867677A patent/AT359507B/de not_active IP Right Cessation
- 1977-12-06 IL IL53552A patent/IL53552A/xx unknown
- 1977-12-07 SE SE7713906A patent/SE430159B/xx unknown
- 1977-12-09 FR FR7737196A patent/FR2374322A1/fr active Granted
- 1977-12-12 IN IN1717/CAL/77A patent/IN146474B/en unknown
- 1977-12-12 YU YU02936/77A patent/YU293677A/xx unknown
- 1977-12-12 FI FI773743A patent/FI65427C/fi not_active IP Right Cessation
- 1977-12-12 US US05/859,928 patent/US4140790A/en not_active Expired - Lifetime
- 1977-12-12 ZA ZA00777398A patent/ZA777398B/xx unknown
- 1977-12-13 SU SU772555706A patent/SU694071A3/ru active
- 1977-12-14 PT PT67403A patent/PT67403B/pt unknown
- 1977-12-14 ES ES465061A patent/ES465061A1/es not_active Expired
- 1977-12-14 NL NL7713827A patent/NL7713827A/xx not_active Application Discontinuation
- 1977-12-14 JP JP14945477A patent/JPS5377073A/ja active Pending
- 1977-12-14 BE BE183452A patent/BE861849A/xx not_active IP Right Cessation
- 1977-12-14 DE DE19772755707 patent/DE2755707A1/de not_active Ceased
- 1977-12-14 GB GB52038/77A patent/GB1580227A/en not_active Expired
- 1977-12-14 CA CA293,096A patent/CA1080219A/en not_active Expired
- 1977-12-14 NO NO774294A patent/NO147306C/no unknown
-
1978
- 1978-12-28 US US05/974,082 patent/US4250310A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SE430159B (sv) | 1983-10-24 |
| NO147306B (no) | 1982-12-06 |
| NL7713827A (nl) | 1978-06-19 |
| PT67403A (en) | 1978-01-01 |
| CA1080219A (en) | 1980-06-24 |
| YU293677A (en) | 1982-08-31 |
| HU174215B (hu) | 1979-11-28 |
| FI773743A (fi) | 1978-06-16 |
| BE861849A (fr) | 1978-03-31 |
| CH632750A5 (de) | 1982-10-29 |
| AT359507B (de) | 1980-11-10 |
| SU694071A3 (ru) | 1979-10-25 |
| JPS6026114B2 (ja) | 1985-06-21 |
| PT67403B (en) | 1979-05-21 |
| US4140790A (en) | 1979-02-20 |
| ZA777398B (en) | 1978-10-25 |
| FI65427B (fi) | 1984-01-31 |
| FI65427C (fi) | 1984-05-10 |
| SE7713906L (sv) | 1978-06-16 |
| FR2374322A1 (fr) | 1978-07-13 |
| IL53552A (en) | 1981-07-31 |
| DE2755707A1 (de) | 1978-06-29 |
| FR2374322B1 (no) | 1981-11-27 |
| JPS5377073A (en) | 1978-07-08 |
| US4250310A (en) | 1981-02-10 |
| JPS5377080A (en) | 1978-07-08 |
| IN146474B (no) | 1979-06-16 |
| NO147306C (no) | 1983-03-16 |
| IL53552A0 (en) | 1978-03-10 |
| ATA867677A (de) | 1980-04-15 |
| GB1580227A (en) | 1980-11-26 |
| ES465061A1 (es) | 1979-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE437022B (sv) | Forfarande for framstellning av n-substituerade morfolinderivat respektive piperidinderivat | |
| NO783442L (no) | Fremgangsmaate ved fremstilling av nye fenylethanolaminderivater | |
| RO70569A (ro) | Procedeu pentru prepararea alchilaminelor heterociclice | |
| NO782768L (no) | Fremgangsmaate for fremstilling av alkenderivater | |
| SE440501B (sv) | Forfarande for framstellning av substituerade fenylamidoximer | |
| SE440772B (sv) | Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat | |
| NO770841L (no) | Fremgangsm}te for fremstilling av nye imidazo-tiazol-derivater | |
| NO784281L (no) | Fremgangsmaate til fremstilling av nye 2alfa-cyano-3-okso-steroider | |
| NO783964L (no) | Fremgangsmaate ved fremstilling av nye prostacyclinderivater | |
| NO773009L (no) | Fremgangsmaate til fremstilling av nye derivater av perhydro-aza-heterocykler | |
| SE438856B (sv) | Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat | |
| SE433212B (sv) | Forfarande for framstellning av 4-hydroxi-aporfin-derivat | |
| NO772431L (no) | Fremgangsm}te ved fremstilling av nye cephalosporinderivater | |
| NO152220C (no) | Fremgangsmaate for fremstilling av sesquiterpenderivat | |
| SE433745B (sv) | Forfarande for framstellning av tetrahydroisokinolinderivat | |
| NO783958L (no) | Fremgangsmaate for fremstilling av nye indolokinolizidiner | |
| NO142625C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater | |
| SE433219B (sv) | Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar | |
| SE443140B (sv) | Forfarande for framstellning av karbostyrilderivat | |
| NO772997L (no) | Fremgangsmaate til fremstilling av nye benzopyranderivater | |
| SE433220B (sv) | Forfarande for framstellning av nya pregnan-derivat | |
| SE431336B (sv) | Analogiforfarande for framstellning av substituerade 8-azapurinderivat | |
| NO773472L (no) | Fremgangsmaate ved fremstilling av nye piperidylidenderivater | |
| NO774294L (no) | Fremgangsmaate ved fremstilling av nye piperazinderivater | |
| NO773073L (no) | Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater |